Increasing Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in the United States
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increasing Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in the United States
Authors
Keywords
Bladder cancer, Neoadjuvant therapy, Chemotherapy, Utilization, Review
Journal
Current Urology Reports
Volume 15, Issue 4, Pages -
Publisher
Springer Nature
Online
2014-02-24
DOI
10.1007/s11934-014-0394-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy
- (2013) Yair Lotan et al. EUROPEAN UROLOGY
- 1435 NEOADJUVANT CHEMOTHERAPY USE IN BLADDER CANCER: A SURVEY OF CURRENT PRACTICE AND OPINIONS
- (2013) Nick Cowan et al. JOURNAL OF UROLOGY
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
- (2012) Joshua J. Meeks et al. EUROPEAN UROLOGY
- 527 CHANGING UTILIZATION OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPIES FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA AFTER PUBLICATION OF LANDMARK MANUSCRIPTS
- (2012) Kirk Keegan et al. JOURNAL OF UROLOGY
- Neoadjuvant and Adjuvant Chemotherapy Approaches for Invasive Bladder Cancer
- (2012) Derek Raghavan et al. SEMINARS IN ONCOLOGY
- Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
- (2012) Adrian S. Fairey et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer
- (2011) Che-Kai Tsao et al. Clinical Genitourinary Cancer
- Identifying Specific Chemotherapeutic Agents in Medicare Data
- (2011) Jennifer L. Lund et al. MEDICAL CARE
- Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
- (2010) Ganesh V. Raj et al. CANCER
- Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007
- (2010) Ugo Fedeli et al. JOURNAL OF UROLOGY
- Baseline Renal Function Status Limits Patient Eligibility to Receive Perioperative Chemotherapy for Invasive Bladder Cancer and Is Minimally Affected by Radical Cystectomy
- (2010) Daniel Canter et al. UROLOGY
- Opposing Views
- (2009) Ralph W. deVere White et al. JOURNAL OF UROLOGY
- Candidate quality of care indicators for localized bladder cancer
- (2009) Matthew R. Cooperberg et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
- (2009) Michael P. Porter et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder
- (2008) Atreya Dash et al. CANCER
- Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
- (2008) David C. Smith et al. JOURNAL OF UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started